Want to join the conversation?
$AGN said FDA approved its supplemental New Drug Application (sNDA) to update label for AVYCAZ (ceftazidime and avibactam) with clinical data from Phase 3 trial evaluating safety and efficacy of AVYCAZ, in combination with metronidazole, for treatment of complicated intra-abdominal infections (cIAI) caused by designated susceptible microorganisms.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.